Are you one of those families racing to find new asthma medications as respiratory virus season approaches? The Massachusetts Department of Public Health is trying to help patients and families access ...

Although bronchial hyperresponsiveness to cholinergic agents is a main feature of asthma, the role of anticholinergic drugs in chronic asthma management has been largely underestimated.

A common inhaler drug used to treat tens of thousands of British asthma sufferers has been linked to a rare and potentially fatal hormone condition in children. New research, funded by the ...

GSK's new long-acting drug candidate for severe asthma, depemokimab, reduced the rate of severe attacks by 54% in a pair of phase 3 trials presented at the European Respiratory Society (ERS ...

A NEW clinical trial has found that the asthma drug montelukast does not shorten the duration of symptoms for ...

It has previously modelled peak sales for the new drug of around £3 billion a year. A trial of AstraZeneca and Avillion's first-in-class asthma rescue inhaler Airsupra has been halted early after ...

Scientists from the University of Sharjah think monoclonal antibodies hold the potential to be a far better treatment for asthma exacerbations ... "Conventional treatments like steroids primarily ...

Upstream Bio garners analyst optimism for its lead drug verekitug, which could disrupt the $7.5 billion asthma biologics ...

Opens in a new tab or window Among patients with mild to moderate COVID-19, the asthma drug montelukast (Singulair) did not reduce duration of symptoms, results of the randomized controlled ACTIV ...

A drug, dupilumab, which blocks IL-4's activity, has been approved by the Food and Drug Administration (FDA) and is already ...